14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
SNY vs UNOV: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Sanofi (SNY) is the stronger overall head-to-head candidate over Innovator U.S. Equity Ultra Buffer ETF - November (UNOV) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SNY carries a Unified Composite Score of 31.7/100 (SELL) at $48.39 (8.9x Forward P/E, 22.3% operating margin), whereas UNOV carries 58.7/100 (HOLD) at $41.13 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While UNOV currently prints a higher short-term Unified Composite Score (58.7/100 HOLD vs. SNY 31.7/100 SELL), SNY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (22.3% vs. N/A operating margin) and revenue trajectory (+15.7% vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNY vs UNOV. Trailing 12-month operating profitability (SNY 22.3% vs UNOV N/A) and valuation multiples (SNY 8.9x vs UNOV N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Pharmaceutical Preparations value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SNY vs UNOV Key Questions & Quantitative Answers
As of Nov 16, 2026, Sanofi (SNY) is the stronger overall head-to-head candidate over Innovator U.S. Equity Ultra Buffer ETF - November (UNOV) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SNY carries a Unified Composite Score of 31.7/100 (SELL) at $48.39 (8.9x Forward P/E, 22.3% operating margin), whereas UNOV carries 58.7/100 (HOLD) at $41.13 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While UNOV currently prints a higher short-term Unified Composite Score (58.7/100 HOLD vs. SNY 31.7/100 SELL), SNY captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (22.3% vs. N/A operating margin) and revenue trajectory (+15.7% vs. N/A YoY).
SNY leads the Growth & Scale pillar: SNY posts +15.7% YoY revenue growth and +9.4% YoY earnings growth on $30.1B TTM revenue (74.3% gross margin, 22.3% operating margin), compared with UNOV at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, SNY generates $30.1B in USD-normalized revenue versus N/A for UNOV. In operating R&D and SG&A reinvestment, SNY deploys 52.0% of Rev ($15.6B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for UNOV.
SNY screens cheaper on headline valuation multiples. SNY trades at 8.9x Forward P/E, 24.1x Trailing P/E, 1.78x PEG, and 3.9x EV/Revenue (29.0% EBITDA margin), whereas UNOV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SNY (5.7% ROE) versus UNOV (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, SNY carries 22.0% implied volatility (43rd %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.21β · 27% Vol realized risk). By comparison, UNOV carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.46β · 11% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.